LUONGO, Livio
 Distribuzione geografica
Continente #
NA - Nord America 3.701
EU - Europa 3.213
AS - Asia 1.071
SA - Sud America 39
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 8.027
Nazione #
US - Stati Uniti d'America 3.693
IE - Irlanda 984
IT - Italia 751
CN - Cina 573
UA - Ucraina 404
GB - Regno Unito 339
DE - Germania 324
SG - Singapore 255
TR - Turchia 162
FI - Finlandia 114
SE - Svezia 93
GR - Grecia 91
FR - Francia 33
BR - Brasile 31
BE - Belgio 25
VN - Vietnam 24
CZ - Repubblica Ceca 18
KR - Corea 17
AT - Austria 8
NL - Olanda 8
CA - Canada 7
JP - Giappone 7
LB - Libano 7
ES - Italia 5
TW - Taiwan 5
DK - Danimarca 4
EC - Ecuador 4
HK - Hong Kong 4
IN - India 4
IR - Iran 4
IQ - Iraq 3
PK - Pakistan 3
RO - Romania 3
CL - Cile 2
RU - Federazione Russa 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
CH - Svizzera 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
JO - Giordania 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
Totale 8.027
Città #
Dublin 980
Chandler 630
Jacksonville 579
Santa Clara 530
Beijing 163
Singapore 158
Bremen 136
Princeton 132
Ann Arbor 123
Naples 112
Wilmington 111
Medford 110
Boardman 108
Ashburn 106
Dearborn 97
Roxbury 90
Cava 86
Caserta 74
Hefei 70
Woodbridge 70
San Mateo 48
Nanjing 47
New York 42
Kunming 39
Mugnano di Napoli 37
Cambridge 36
Des Moines 33
Munich 29
Napoli 28
Jinan 27
Aversa 25
Brussels 25
Dong Ket 24
Helsinki 24
Houston 24
Rome 24
Istanbul 22
Mountain View 21
Düsseldorf 20
Brno 18
Guangzhou 18
Seoul 17
Norwalk 15
Nanchang 13
Shenyang 13
Hanover 12
Hebei 12
Milan 12
Auburn Hills 11
Los Angeles 10
Redwood City 10
Venice 10
Zhengzhou 10
Afragola 9
Arzano 9
Ningbo 9
Shanghai 9
Paris 7
Falls Church 6
Izmir 6
Santa Maria Capua Vetere 6
Shaoxing 6
Xian 6
Aiello del Sabato 5
Campinas 5
Chengdu 5
Hangzhou 5
Lappeenranta 5
Mcallen 5
Modena 5
Taipei 5
Casoria 4
Chaoyang 4
Elora 4
Florence 4
Frederiksberg 4
Lanzhou 4
Nuremberg 4
Pioltello 4
Shenzhen 4
Tappahannock 4
Vienna 4
Altamura 3
Amsterdam 3
Andover 3
Baotou 3
Bonea 3
Centrale 3
Changsha 3
Chongqing 3
Clifton 3
Ercolano 3
Frankfurt am Main 3
Fuzhou 3
Grafing 3
Guayaquil 3
Gunzenhausen 3
Hong Kong 3
Huzhou 3
Marigliano 3
Totale 5.432
Nome #
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation. 140
SOSTITUZIONE BIOISOSTERICA DEL GRUPPO AMMIDICO DI 4-CHINOLON-3-CARBOSSAMIDI6-SOSTITUITE:LIGANDI CB2 POTENTI E SELETTIVI PROVVISTI DI MIGLIOR PROFILO CHIMICO-FISICO . 135
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice. 111
D-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice. 110
USO DEI BISFOSFONATI PER LA PREPARAZIONE DI FORMULAZIONI FARMACEUTICHE PER IL TRATTAMENTO DEI SINTOMI ASSOCIATI A DOLORE NEUROPATICO 109
MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice 104
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 103
1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihy droindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice 99
Chalcone derivatives activate and desensitize the transient receptor potential ankyrin 1 cation channel, subfamily A, member 1 TRPA1 ion channel: structure-activity relationships in vitro and anti-nociceptive and anti-inflammatory activity in vivo 97
Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo. 96
1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice. Neurobiol Dis. 2010 Jan;37(1):177-85. Epub 2009 Oct 3. PubMed PMID: 19804829 95
Endocannabinoid Research Group (ERG), Italy. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 92
Neuroimmune-driven neuropathic pain establishment: A focus on gender differences 89
Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions. 88
The antinociceptive effect of 2-chloro-2'-C-methyl-N6-cyclopentyladenosine (2'-Me-CCPA), a highly selective adenosine A1 receptor agonist, in the rat 85
Age-Related Changes in D-Aspartate Oxidase Promoter Methylation Control Extracellular D-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging 85
EP1 receptor within the ventrolateral periaqueductal grey controls thermonociception and rostral ventromedial medulla cell activity in healthy and neuropathic rat 84
Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: Involvement of the CB2 receptor 83
Palmitoylethanolamide reduces neuropsychiatric behaviors by restoring cortical electrophysiological activity in a mouse model of mild traumatic brain injury 83
Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection. 81
Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model. 80
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress. 79
Metabotropic glutamate receptor subtype 7 in the dorsal striatum oppositely modulates pain in sham and neuropathic rats 79
Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats 78
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. 78
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 78
5'-Chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A(1) receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions. Molecules. 78
Exposure to allergen causes changes in nts neural activities after intratracheal capsaicin application, in endocannabinoid levels and in the glia morphology of nts 78
The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats. 77
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways 76
The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression. 75
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 75
Uso di bifosfonati per la preparazione di formulazioni farmaceutiche per il trattamento dei sintomi associati a dolore neuropatico. 75
Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity 74
Intraperiaqueductal gray glycine and D-serine exert dual effects on rostral ventromedial medulla ON- and OFF-cell activity and thermoceptive threshold in the rat 73
PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity 72
The A1 adenosine receptor as a new player in microglia physiology 71
The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. 71
The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice. 70
The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats 70
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 69
Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain 69
Effect of Prolonged Moderate Exercise on the Changes of Nonneuronal Cells in Early Myocardial Infarction. 69
Palvanil, a non-pungent capsaicin analogue, inhibits inflammatory and neuropathic pain with little effects on bronchopulmonary function and body temperature. 69
Effects of a metabotropic glutamate receptor subtype 7 negative allosteric modulator in the periaqueductal grey on pain responses and rostral ventromedial medulla cell activity in rat 68
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity 68
Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchi. 67
Role of metabotropic glutamate receptor 1 in the basolateral amygdala-driven prefrontal cortical deactivation in inflammatory pain in the rat 67
The 17-estradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression 67
d-Aspartic acid ameliorates painful and neuropsychiatric changes and reduces β-amyloid Aβ1-42 peptide in a long lasting model of neuropathic pain. 67
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy 66
Intra-Periaqueductal Gray glycine and D-serine exert dual effects on the Rostral Ventromedial Medulla ON and OFF cell activity and thermal threshold in the rat 66
Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach 66
CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity 66
Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain. 66
Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice 65
Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels. 64
Transient receptor potential vanilloid type 1 and pain development. 63
Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. 63
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice 63
Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice 62
Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists. 62
Behavioral, Biochemical and Electrophysiological Changes in Spared Nerve Injury Model of Neuropathic Pain 62
Moving towards supraspinal TRPV1 receptors for chronic pain relief 61
5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists. 61
Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice. 61
Nociception modulation by supraspinal group III metabotropic glutamate receptors 61
d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain 60
Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol. 60
The galactosylation of N()-nitro-L-arginine enhances its anti-nocifensive or anti-allodynic effects by targeting glia in healthy and neuropathic mice 60
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. 59
Spinal changes associated with mechanical hypersensitivity in a model of Guillain-Barré syndrome 58
Metabotropic glutamate receptor subtype 8 in the amygdala modulates thermal threshold, neurotransmitter release, and rostral ventromedial medulla cell activity in inflammatory pain. 58
Role of endocannabinoids in neuron-glial crosstalk 58
Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE) 58
Pharmacological activity of a Bv8 analogue modified in position 24. 57
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation. 57
Exploring the Role of N(6)-Substituents in Potent Dual Acting 5'-C-Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice ∇ 56
Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats. 55
The role of cannabinoid receptors in the descending modulation of pain 54
Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions. 54
Relationship between blood lactate and cortical excitability between taekwondo athletes and non-athletes after hand-grip exercise 54
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice 54
Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol. Neuro Endocrinol Lett. 2010;31(4):507-11. PubMed PMID: 20802454 53
Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1 R signaling and anxiety-like behavior. 53
Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels via astrocyte-dependent mechanisms. 53
The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum. 53
New Insights on Neuropathic Pain Mechanisms as a Source for Novel Therapeutical Strategies 52
TRPV1-Dependent and -Independent Alterations in the Limbic Cortex of Neuropathic Mice: Impact on Glial Caspases and Pain Perception 51
Platelet-rich plasma exerts antinociceptive activity by a peripheral endocannabinoid-related mechanism 51
Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway Underlies Altered Pain Perception in Leptin Signaling Deficiency. 50
Celecoxib Prevents Cognitive Impairment and Neuroinflammation in Soluble Amyloid β-treated Rats 50
Pharmacological Considerations for the Use of General Anesthetics in the Elderly 50
5'-Chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A1 receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions 49
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist. 48
Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and antihyperalgesic effects in mice. 47
2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors. 46
Adenosine Metabotropic Receptors in Chronic Pain Management 46
Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: Cannabinoid and non-cannabinoid receptor-mediated mechanisms 45
Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions 45
Totale 6.988
Categoria #
all - tutte 33.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.680


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020838 0 0 0 0 0 112 382 178 69 45 41 11
2020/2021983 60 16 114 43 113 16 223 96 22 110 119 51
2021/2022978 66 14 11 15 277 21 24 26 43 134 80 267
2022/20232.332 151 52 42 248 314 203 9 174 1.037 19 40 43
2023/2024839 81 43 31 52 238 53 16 113 8 5 45 154
2024/2025993 32 23 93 129 414 302 0 0 0 0 0 0
Totale 8.423